Dec 3 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 14 points lower at 6,449 on Thursday, according to financial bookmakers.
ASTRAZENECA: AstraZeneca Plc AZN.L will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief adviser for the U.S. government's Operation Warp Speed program said on Wednesday.
GOLD: Gold rose to an over one-week high as the dollar weakened on hopes of coronavirus vaccine roll-outs, while investors also weighed the possibility of more U.S. stimulus.
OIL: Oil prices fell as producers including Saudi Arabia and Russia locked horns over the need to extend record production cuts set in place in the first wave of the COVID-19 pandemic.
The UK blue-chip index .FTSE closed 1.2% higher on Wednesday as the sterling weakened on doubts of whether a trade deal could be reached by Britain and the European Union, while the UK's approval of a COVID-19 vaccine also supported sentiment.
* UK CORPORATE DIARY:
Countryside Properties Plc CSPC.L
FY earnings Go Ahead Group
Trading update AJ Bell Plc
FY earnings Caretech Holdings Plc
FY earnings Paragon Banking Group Plc
FY earnings Phoenix Group Holdings Plc PHNX.L